“RIP1 Kinase Inhibition: A Potential Non-Immunosuppressive Treatment for Graft-versus-Host Disease”

https://pubmed.ncbi.nlm.nih.gov/38117900

Inhibition of RIP1 kinase offers a potential non-immunosuppressive treatment for graft-versus-host disease (GVHD) by improving immune reconstitution, reducing GVHD-associated mortality, and preserving graft-versus-leukemia effects.